PB2098: ‘REAL-WORLD’ TREATMENT PATTERNS AND PATHWAYS OF SECOND LINE DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN UK, CANADA, FRANCE, GERMANY, ITALY AND SPAIN USING A PROSPECTIVE SURVEY OF PHYSICIANS

• A. Bailey,
• N. Milloy,
• I. Sanderson,
• J. Butcher,
• C. Spooner,
• D. Kilic,
• S. Vadgama

Affiliations

A. Bailey

1 Oncology, Adelphi Real World, Bollington

N. Milloy

1 Oncology, Adelphi Real World, Bollington

I. Sanderson

1 Oncology, Adelphi Real World, Bollington

J. Butcher

1 Oncology, Adelphi Real World, Bollington

C. Spooner

2 Kite, a Gilead company, Uxbridge, United Kingdom

D. Kilic

2 Kite, a Gilead company, Uxbridge, United Kingdom

S. Vadgama

2 Kite, a Gilead company, Uxbridge, United Kingdom